Skip to main content

Table 2 Hemodynamic parameters

From: Effects on hemodynamics and gas exchange of omega-3 fatty acid-enriched lipid emulsion in acute respiratory distress syndrome (ARDS): a prospective, randomized, double-blind, parallel group study

  T-0 h (baseline, preinfusion) T-6 h T-12 h (final infusion) T-18 h (6 h postinfusion)
HR     
A: n-3 91 ± 19 101 ± 20 100 ± 21 91 ± 25
B: LCT 95 ± 13 93 ± 12 95 ± 12 84 ± 16
CO     
A: n-3 7.8 ± 2.8 8.4 ± 2.7 8.5 ± 2.7 7.8 ± 3
B: LCT 6.9 ± 1.3 7.3 ± 1.9 6.8 ± 1.6 6.1 ± 1.3
SAP     
A: n-3 127 ± 19 113 ± 14 117 ± 15 131 ± 24
B: LCT 126 ± 9 126 ± 10 124 ± 14 121 ± 14
MPAP     
A: n-3 26 ± 5 29 ± 4 28 ± 7 28 ± 6
B: LCT 30 ± 7 31 ± 7 31 ± 6 28 ± 7
PW     
A: n-3 13 ± 4* 13 ± 2 14 ± 3 14 ± 4
B: LCT 16 ± 2 17 ± 2 17 ± 2 16 ± 2
PVR     
A: n-3 162 ± 122 187 ± 98 155 ± 68 162 ± 92
B: LCT 147 ± 84 142 ± 102 138 ± 79 134 ± 77
SVR     
A: n-3 822 ± 328 644 ± 194 629 ± 228 864 ± 376
B: LCT 863 ± 217 840 ± 274 884 ± 298 932 ± 238
DO 2     
A: n-3 1074 ± 340 1171 ± 406 1174 ± 372 1066 ± 518
B: LCT 966 ± 224 1023 ± 330 936 ± 227 856 ± 225
VO 2 /DO 2     
A: n-3 0.22 ± 0.04 0.24 ± 0.05 0.23 ± 0.04 0.25 ± 0.06
B: LCT 0.26 ± 0.05 0.25 ± 0.04 0.27 ± 0.03 0.25 ± 0.04
Q s /Q t     
A: n-3 33 ± 10 31 ± 8 33 ± 11 28 ± 7
B: LCT 28 ± 11 27 ± 6 25 ± 8 25 ± 9
BT     
A: n-3 38.1 ± 1 38 ± 0.9 38.1 ± 0.8 37.6 ± 1.2
B: LCT 37.6 ± 0.4 37.5 ± 0.6 37.6 ± 0.4 37.1 ± 1
  1. HR: heart rate, CO: cardiac output, SAP: systolic artery pressure, MPAP: mean pulmonary artery pressure, PW: pulmonary artery occlusion pressure, PVR: pulmonary vascular resistances, SVR: systemic vascular resistances DO2: oxygen delivery, Qs/Qt: venous admixture ratio, BT: body temperature.
  2. * p < 0.05 between baseline groups